South African sell-down: Slaughters leads as GSK exits Aspen Pharmacare

Legal Business · 3 October 2016 · 1 min read

Corporate and M&A Deal watch Cleary Gottlieb Slaughter and May

Slaughter and May, Cleary Gottlieb Steen & Hamilton and Bowman Gilfillan advised GlaxoSmithKline (GSK) on the sale of its remaining 6.2% stake in Aspen Pharmacare, announced last week.

This article is for Legal Business subscribers. Please log in or subscribe to read on.